Harry Griendling, Founder and CEO, DoubleStar
Because demand for talent is outstripping supply for Pharma/Biotech talent, employers need to capture a disproportionate share of talent to meet growth. To accomplish this, employers need to urgently change their approach to Talent Acquisition to increase their impact in talent strategy, redefine employment propositions, and better make clear business cases for new initiatives. This presentation will offer detailed ideas and models for how to create a new, market-driven approach to designing and measuring the impact of talent acquisition on an organization’s business results.
[su_button url="http://the-tma.org/lifesciences/agenda/" target="blank" background="#336666" size="7" icon="icon: arrow-left"]Back to the agenda page[/su_button] [su_button url="https://www.regonline.com/registration/Checkin.aspx?EventID=1887358" background="#da0f12" size="7" icon="icon: check-square-o"]Register Now![/su_button]